Skip to main
IMNM
IMNM logo

Immunome (IMNM) Earnings Dates & Reports

Immunome (IMNM) Most Recent Earnings

Report DateAug 6, 2025
Period EndingQ2 2025
Est. EPS-$0.51
Actual EPS-$0.50
EarningsBeat

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Immunome (IMNM) Earnings per Share (EPS) History

Signup for full access
Browse free

Immunome (IMNM) Latest Earnings

The value each IMNM share was expected to gain vs. the value each share gained.

Immunome (IMNM) reported its most recent earnings on Aug 6, 2025 for Q2 2025, posting earnings per share (EPS) of -$0.50. This exceeded analysts' expectations of -$0.51 by 1.96%, marking a Beat.

For comparison, Immunome reported EPS of -$0.60 in the same quarter last year.

The company is expected to announce its next earnings report on 11/12/2025, with analysts projecting an EPS of -$0.55.

Immunome (IMNM) Earnings History

Earnings
Est. EPSActual EPSSurprise
Q3 2025Nov 12, 2025
-$0.55Next earnings call Nov. 12, 2025
Q2 2025Aug 6, 2025
-$0.51-$0.50-1.96%
Q1 2025May 12, 2025
-$0.57-$0.52-8.77%
Q4 2024Mar 19, 2025
-$0.72-$1.28+77.78%
Q3 2024Nov 13, 2024
-$0.56-$0.78+39.29%
View all

Immunome (IMNM) Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Immunome’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange
Aug 6, 2025
May 12, 2025
Mar 19, 2025
Nov 13, 2024

Immunome (IMNM) Earnings FAQs

Immunome (IMNM) last reported earnings on Aug 6, 2025 for Q2 2025, posting an EPS of -$0.50, which Beat the estimate of -$0.51 by 1.96%.

For Q2 2025, Immunome (IMNM) reported an EPS of -$0.50, exceeding analysts' estimate of -$0.51 by 1.96%.

For Q2 2025, Immunome (IMNM) Beat expectations with an actual EPS of -$0.50 vs. an estimated EPS of -$0.51.

Following the last earnings report on Aug 6, 2025, Immunome (IMNM)'s stock price moved — from — to —.

The next Immunome (IMNM) earnings call is scheduled for Nov. 12, 2025, where executives will discuss financial results and outlook.

Immunome (IMNM)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.